NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Institute for Cancer Research

 

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.

The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Øystein Fodstad<br>Scientific director
Øystein Fodstad
Scientific director

Scientific production - Institute for Cancer Research

  Publications
2011 so far
2010 197
2009 166
2008 139

Department overview

 
>> Print this page  [81451 visits]

Latest news

NBS prizes to PhD students from Institute for Cancer Research

 
Simona Kavaliauskiene (left) and Angela Oppelt
Simona Kavaliauskiene (left) and Angela Oppelt
The Norwegian Biochemical Society arranged its 48th Contact Meeting at Storefjell, January 19th-22nd, 2012, and high quality science was presented both in lectures and as posters.
Two PhD students at the Dept. of Biochemistry and CCB at the Institute for Cancer Research, Simona Kavaliauskiene (Sandvig’s group) working with membrane transport, and Angela Oppelt (Wiedlocha’s group) studying cell movement, were honored by a poster-prize and a prize for an excellent lecture, respectively.

More  
 
 

Institute seminars spring season 2012

 
The complete list of seminars at the Institute for Cancer Research to be held the spring season of 2012 is now ready.

The upcoming seminar on Wednesday January 25th will be held by Pierre Åman from Cancercentrum, Sahlgrenska Hospital, Göteborg, Sweden (invited by Ola Myklebost, Dept. of Tumor Biology).

The institute seminars are held in the new research building at Montebello (photo) on Wednesdays from 12-13.

More  
 
 

Aiming at national support for targeted cancer therapy research

 
O. Myklebost
O. Myklebost

Oslo Cancer Cluster recently arranged their annual "Cancer Crosslinks Seminar". This year the subject was targeted cancer therapy. Among the lecturers was professor Ola Myklebost, senior researcher at the Department of Tumor Biology and leader of The Norwegian Cancer Genomics Consortium (NCGC).

2011 was the starting year for a governmental research programme for clinical cancer studies, administered by the Norwegian Research Council. The theme area for the announcement is "individually adapted cancer treatment". A sum amounting to 100 mill NOK will be distributed over a period of 5 years and 60 mill NOK was announced this autumn. The NCGS has applied for support for a research project spanning 3 years for studying genetic changes in tumors.


More